ARIS vs AVNT

ARIS exhibits a stable financial health profile with a Piotroski F-Score of 4/9 and a strong balance sheet characterized by low debt/equity (0.36). While the company is delivering explosive triple-digit growth in revenue (104.2%) and earnings (121.7%), the stock is significantly overvalued, trading at $18.76 against a Graham Number of $8.06 and an Intrinsic Value of $12.09. The combination of a bearish technical trend (0/100) and a high P/E ratio suggests that the market has already priced in much of the future growth, creating a high-risk entry point despite strong fundamentals.

Avient Corporation exhibits a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score to confirm safety from distress. While profitability metrics and recent earnings surprises are positive, declining revenue and earnings growth, coupled with a high payout ratio and elevated valuation, constrain long-term appeal. The stock trades above both the Graham Number ($26.67) and intrinsic value estimate ($8.54), suggesting overvaluation on defensive and growth criteria. However, strong short-term price momentum and analyst consensus of 'strong_buy' provide counterbalancing support.